Hologic’s HOLX GYN Surgical segment posted fourth-quarter revenues of $172.5 million, up 10.2% year over year. This marked ...
The Bulldogs dominated the glass and in the paint, led by Michael Ajayi, in their tournament opener against the Gamecocks.
Johnson & Johnson (JNJ) 7th Annual Wolfe Research Healthcare Conference November 17, 2025 10:40 AM ESTCompany ParticipantsCandice Long - Worldwide ...
ABBV's neuroscience drugs drive strong Q3 momentum, with rising Botox Therapeutic sales, migraine therapies and new PD ...
Guselkumab (Tremfya; Johnson & Johnson) continued to reduce signs and symptoms of active psoriatic arthritis (PsA) and ...
YouTube on MSN
How The One-Shot COVID Vaccine Changes Things
The Johnson & Johnson COVID-19 vaccine is now the third approved for emergency use authorization in the United States, and it ...
A strong year for initial public offerings on Wall Street has fizzled out due to the government shutdown and a cautious turn ...
Kenvue Inc. (NYSE:KVUE) is one of the stocks on Jim Cramer’s radar recently. During the lightning round, a caller asked if ...
2don MSN
US filings for jobless benefits remained in historically healthy range during government shutdown
New U.S. jobless claim applications fell last week, remaining within the healthy range of recent years, according to the ...
Bristol Myers Squibb and Johnson & Johnson to discontinue phase 3 Librexia ACS trial of milvexian treat acute coronary syndrome: Princeton, New Jersey Monday, November 17, 2025, 1 ...
With phase I/II data in hand, Taiho Pharmaceutical Co. Ltd. and Cullinan Therapeutics Inc. began filing a rolling NDA to the U.S. FDA for accelerated approval of zipalertinib to treat patients with ...
Merck has announced plans to acquire Cidara Therapeutics for $9.2 billion, or $221.50 per share. Representing a heavy premium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback